| Literature DB >> 35385738 |
Desiree M Baron1, Adam R Fenton2, Sara Saez-Atienzar3, Anthony Giampetruzzi1, Aparna Sreeram1, Pamela J Keagle1, Victoria R Doocy1, Nathan J Smith4, Eric W Danielson1, Megan Andresano1, Mary C McCormack1, Jaqueline Garcia1, Valérie Bercier5, Ludo Van Den Bosch5, Jonathan R Brent6, Claudia Fallini7, Bryan J Traynor8, Erika L F Holzbaur2, John E Landers9.
Abstract
Understanding the pathogenic mechanisms of disease mutations is critical to advancing treatments. ALS-associated mutations in the gene encoding the microtubule motor KIF5A result in skipping of exon 27 (KIF5AΔExon27) and the encoding of a protein with a novel 39 amino acid residue C-terminal sequence. Here, we report that expression of ALS-linked mutant KIF5A results in dysregulated motor activity, cellular mislocalization, altered axonal transport, and decreased neuronal survival. Single-molecule analysis revealed that the altered C terminus of mutant KIF5A results in a constitutively active state. Furthermore, mutant KIF5A possesses altered protein and RNA interactions and its expression results in altered gene expression/splicing. Taken together, our data support the hypothesis that causative ALS mutations result in a toxic gain of function in the intracellular motor KIF5A that disrupts intracellular trafficking and neuronal homeostasis.Entities:
Keywords: ALS; CP: Neuroscience; KIF5A; amyotrophic lateral sclerosis; autoinhibition; axonal transport; kinesin; neurodegenerative disease; neuronal survival
Mesh:
Substances:
Year: 2022 PMID: 35385738 PMCID: PMC9134378 DOI: 10.1016/j.celrep.2022.110598
Source DB: PubMed Journal: Cell Rep Impact factor: 9.995